Bill Title: Amends the Prior Authorization Reform Act. Provides that notwithstanding any other provision of law, a health insurance issuer or a contracted utilization review organization may not require a prior authorization for drug therapies approved by the U.S. Food and Drug Administration for the treatment of hereditary bleeding disorders any more frequently than 6 months or the length of time the prescription for that dosage remains valid, whichever period is shorter. Effective January 1, 2026.

Spectrum: Moderate Partisan Bill (Republican 9-1)

Status: (Passed) 2024-07-19 - Public Act . . . . . . . . . 103-0659 [HB4055 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Chaptered	2024-07-22	HTML/Text	Link	View
Enrolled	2024-05-16	HTML/Text	Link	View
Engrossed	2024-04-19	HTML/Text	Link	View
Introduced	2023-04-27	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
House Amendment 002	2024-04-09	Proposed	HTML/Text	Link	View
House Amendment 001	2024-04-02	Proposed	HTML/Text	Link	View

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for Illinois HB4055 currently on file.

Social Comments on IL HB4055